"10.1371_journal.pone.0131497","plos one","2015-06-30T00:00:00Z","Matthew J Marton; Andrew R McNamara; D Michele Nikoloff; Aki Nakao; Jonathan Cheng","Merck Research Laboratories, Molecular Biomarkers and Diagnostics, Rahway, New Jersey, United States of America; Roche Molecular Systems, Inc., Pleasanton, California, United States of America; Merck Research Laboratories, Clinical Oncology, North Wales, Pennsylvania, United States of America","Conceived and designed the experiments: MJM DMN AN JC. Performed the experiments: DMN. Analyzed the data: DMN AN ARM. Contributed reagents/materials/analysis tools: MJM DMN AN ARM JC. Wrote the paper: MJM ARM DMN AN JC.","The authors are (or were) employees of either Roche Molecular Systems, Inc. or Merck Research Laboratories. Aki Nakao has filed patent applications US20140128270 A1 and WO2014072309 A1 and the algorithm described in these patent applications was implemented as a part of the AmpliChip p53 Research Test Analyzer algorithm. Matthew Marton and Jonathan Cheng both own Merck stock. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","06","Matthew J Marton","MJM",5,TRUE,4,1,3,5,TRUE,FALSE,FALSE,0,NA,FALSE
